ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting ...
Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according ...
Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...
Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...
Over the last several years, the RxSight team has been developing proprietary hybrid IOL materials for next-generation light adjustable technology that can support a full suite of adjustable lenses ...
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...
RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...
When you spot an item you love on social media or while out and about, Amazon Lens is the quickest way to find similar items in the Amazon Shopping app. Now, we’re making Amazon Lens even better with ...
Alcon’s ALC new platforms and lenses are gaining adoption. Dry eye momentum is likely to support growth in the upcoming ...
Live News Alcon AG Analyst Outlook - macroeconomic data, inflation trends, and interest rates tracking. Some traders rely on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results